Kanuma

(sebelipase alfa)
10 ML sebelipase alfa 2 MG/ML Injection [Kanuma]
NO BLACK BOX WARNING

Dosage & administration

Infants with Rapidly Progressive LAL Deficiency Presenting within the First 6 Months of Life:

Pediatric and Adult Patients with LAL Deficiency:


See Full Prescribing Information for complete Dosage and Administration Information.

Administration Instructions


Most viewed Kanuma resources

Enroll in Patient Savings Program

drug label

Kanuma prescribing information

Have more Kanuma questions?

Submit MSL Request
Learn More

Need to report a Kanuma issue?

ONLINE FORM
Report adverse event
Learn More

prior authorization

Kanuma Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRAND
Coverage Authorization Request

NOT PROVIDED BY BRAND
Coverage Authorization Appeals
Learn More

Benefits investigation

Kanuma OneSource Enrollment Form
Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

financial assistance

Kanuma Financial assistance options

Co-pay savings program

commercial only
Kanuma OneSource Enrollment Form
Enroll in Patient Savings Program
Learn More

Bridge program

commercial only
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Learn More

patient education

Kanuma Patient education

Getting started on Kanuma

NOT PROVIDED BY BRAND
Instructions For Use - Lysosomal Acid Lipase Deficiency (LAL-D)

Patient toolkit

NOT PROVIDED BY BRAND
Not Provided By Brand
Learn More

people also ask

Kanuma FAQs

FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:
Please note:
  • Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
  • Samples are provided at the discretion of the brand.
  • We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.